Yarahmadi A, Afkhami HJFiO
For some people, semaglutide can take things too far
During the first eight weeks, which covers the 0.25 mg and 0.5 mg doses, average weight loss hovers around a modest 1.1 to 1.5 percent of total body weight
In contrast, SGLT2 inhibitors and GLP-1 receptor agonists are newer standard therapies that reduce glycemia while conferring proven cardiovascular and renal benefits, making them preferred agents for improving outcomes beyond HbA1c reduction alone
Keep in mind, too, that the head-to-head study compared Zepbound against Wegovys 2.4 mg dose
The main ingredient deoxycholic acid is actually something your body naturally produces to break down dietary fat